view of our findings, however, serial measurements for individual patients should always be taken using the same model, even if it is impracticable to use the same instrument.
The inaeased risk of subarachnoid haemorrhage-associated with oral contraception is a matter of debate.' Most studies indicate that there-is a small but significandy increased risk. 2 The reason for this association remains obscure, although Thorogood et al proposed that the hypertensive action of the pill has an indirect effect. 3 We report on three'patients taking oral contraceptives who developed cerebral venous thrombosis and subarachnoid haemorrhage of varying severity.
Case reports
Case I-A 30 year old Kenyan woman was found unconscious at home having complained earlier of headache and nausea Three months previously she had been prescribed Diane (cyproterone acetate 2 mg, ethinyloestradiol 50 gig) for acne. On examination she was obese, comatose, and tachypnoeic with a temperature of 37-60C. She flexed her arms and legs to painfiu stimuli and had bilateral extensor plantar responses. Her eyes were deviated to the left, doll's eye movements were present, and her optic fundi were normal. Investigation showed a haemoglobin concentration of 104 g/l, neutrophilia of 15'4 x 109/1, and blood glucose concentration of 16-6 mmol/ (299 mg/100 ml). Enhanced computed tomography yielded normal results. Examination of cerebropinal fluid showed 5 x 109 red blood cells/I, 7 x 10' polymorph white cells/l, and a protein concentration of 0-4 g/l. The opening pressure was 400 mm water. After admission her condition deteriorated rapidly; she required ardfcial ventilation and died three days later. Postmortem xm tion showed venous infartion of the cerebellum and brain stem secondary to multiple inuacrnial venous thromboses.
Case 2-A previously healthy woman aged 26 presented with a headache that had worsened progressively over seven days and was associated with unsteady gait, nausea, and vomiting. She Thirty ninie healthy subjects consented tO participate in the study. Only four knew that they had received vaccinations against diphtheria or tetanus, or both, within the preceding 10 years. All but one, however, had probably been immunised during infancy or in school with a combined diphtheria and tetanus vaccine. The vaccine contained formaldehyde detoxified, aluminium adsorbed diphtheria and tetanus toxins, 25 and 75 flocculation units/ml respectively (SBL, Sweden). The subjects were randomised by using sealed envelopes to receive the vaccine subcutaneously (21 subjects) or intracutaneously (18). The mean age was 29-8 (range 23-43) years, with no difference between the groups. Seven of the eight women were randomised to receive the vaccine subcutaneously. Before vaccination all subjects were Schick tested using standardised reagents (SBL, Sweden). After four days the reactions to the toxin and a heat inactivated control were determined. Induration with a diameter of .10 mm at the site of application of the Schick reagent and at least 500/o smaller reactions to the control reagent were considered to indicate lack of immunity. Reactions with a diameter < 10 mm were interpreted as indicating immunity, and reactions with a diameter >10 mm but no appreciable difference between the reagents were interpreted as pseudoreactions-that is, indicating possible hypersensitivity to an agent in the vaccine.
Serum samples were collected from all subjects before and four weeks after vaccination and analysed for antibodies to diphtheria toxin using a microcell culture technique.2 Each sample was tested in fourfold dilution from 1:4 to 1:4096, corresponding to antitoxin titres, if positive, from 0-0025 to 2-56 IU. Subjects with titres -0-0025 IU were considered to be non-immune, those with titres between 0-001 and 0-004 IU to be partially immune, and those with titres >0-04 IU to be immune. 
